VEITINGER KLAUS R DR 4
4 · scPharmaceuticals Inc. · Filed Jun 15, 2022
Insider Transaction Report
Form 4
VEITINGER KLAUS R DR
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-14+16,300→ 16,300 totalExercise: $4.53Exp: 2032-06-14→ Common Stock (16,300 underlying)
Footnotes (1)
- [F1]This stock option vests in full upon the earlier of (i) June 14, 2023, or (ii) the next annual meeting of the Issuer's stockholders.